vivo. Loss of the transduced genetic material over time may be caused by the limited ability of retroviral infection to transduce genes into early, pluripotent hematopoietic stem cells. Because fetal liver contains actively proliferating multipotential stem cells that should be more susceptible t o retroviral-mediated gene transfer than quiescent cells derived from adult bone marrow, these cells may be an ideal target for gene transduction. Furthermore, physiologic expansion of these cells during development obviates the need for marrow ablation during gene therapy in vivo. We performed in utero gene transfer by injecting high titer replicationdefective retrovirus in vivo into the livers of 11,14,16, and 18 day gestation rats. After birth, the rats were analyzed for the presence of proviral integration and gene expression. The efficiency of gene transfer into bane marrow cells was
UCCESSFUL INTRODUCTION of foreign genes into
S hematopoietic stem cells in animals may lead to a better understanding of gene expression and the pathogenesis of genetic disorders, and may ultimately be used to correct genetic mutations in vivo. The most commonly used methodology to perform gene transfer into hematopoietic stem cells involves placing the target gene within a replication defective retrovirus, transducing bone marrow (BM) cells with retrovirus in vitro and engrafting these cells into the animal by BM transplantation (BMT).IJ Many laboratories have successfully demonstrated gene transfer into colony-forming unit-spleen (CFU-S) and other hematopoietic progenitors. However, there has been less success in demonstrating long-term reconstitution of retrovirally transfected genes in the transplanted animals, especially in animals other than the m0use.4~~~' Lack of long-term recon-greatest in rats infected at day 14 t o 16 of gestation. In rats killed at 1 t o 26 weeks of age, gene transfer was detected by Southern analysis in 48% and by polymerase chain reaction in 86% of bone marrow samples. The provirus was also detected in white blood cells, the granulocyte-macrophage colony-forming unit, thymus, spleen, liver, and lung. The presence of the transgene in bone marrow and other hematopoietic tissues at 26 weeks of age suggests that early hematopoietic precursors present in the fetal liver are susceptible targets for gene transfer and that these cells become resident in the bone marrow of the adult animal. This model is a new technique for gene transduction into proliferating hematopoietic cells in vivo that avoids bone marrow transplantation and has potential application in the correction of genetic defects in utero. 0 1991 by The American Society of Hematology.
stitution most likely signals failure of the gene transduction to take place in early totipotent hematopoietic stem c e k 8 These cells are both few in number in the adult BM and they are quiescent. Because retroviral-mediated gene transduction is more efficient in actively proliferating cells, where the retrovirus can efficiently undergo reverse transcription and proviral integration, totipotent stem cells may be difficult to tran~duce."~ While committed hematopoietic progenitors can be induced into cell cycle by recombinant hematopoietic growth factors in vitro and therefore incorporate totipotent stem cells respond less quickly to growth factors, often only after a number of day^'^.'^ and thus remain difficult targets for retroviral gene transduction. For this reason, we turned to fetal hematopoietic cells where totipotent hematopoietic stem cells have the greatest likelihood of being in cell c y~l e . '~,~~ During early fetal development, these cells are actively proliferating and expanding in number to establish the neonatal BM. Ekhterae et a1 have demonstrated a greater efficiency of retroviralmediated gene transfer in fetal hematopoietic progenitors than progenitors from adult BM using standard in vitro coculture techniques." Kantoff et all8 removed hematopoietic cells from the circulation of a fetal sheep during midgestation, infected these cells in vitro with a replicationdefective retrovirus, returned the cells to the fetus by an intravascular catheter," and documented persistent gene transduction in one sheep 2 years later.
Direct in utero gene transfer by injection of recombinant retrovirus has been described in several studies. The initial procedure used a replication-competent virus injected into mouse embryo^.'^ More recently, Compere et a1 used a replication incompetent virus containing H-rus injected into the amniotic saczo at 8 days gestation. Cells containing the provirus expressed H-rus, had a growth advantage, and were detected as neoplastic nodules. In our previous study, we used a replication incompetent virus carrying the chimeric phosphoenolpyruvate (GTP)-carboxykinase-bovine growth hormone gene to perform gene transduction in 
MATERIALS AND METHODS

Animal Model
Artificially inseminated pregnant Sprague-Dawley rats (ZivicMiller, Allison Park, PA) were used. In utero injection into the fetal liver was performed at day 11, 14. 16, or 18 of gestation by a modification of the technique described by Hatzoglou et al." Briefly, the pregnant rats were anesthetized. the abdomen was sterilely prepped, and a midline abdominal incision performed. The uterine horns were externalized and the fetuses were oriented within the amniotic sac such that direct visualization and injection of the fetal liver could be accomplished. Twenty-five microliters (day 11 of gestation). 50 pL (day 14). or 100 pL (day 16 and 18) of retrovirus was injected into the liver of each fetus. The uterine horns were then returned to the abdomen, the maternal peritoneum closed in two layers, and the fetuses were allowed to complete gestation and to deliver normally.
Chemicals and Reagents
Tissue culture reagents were obtained from K.C. Biological Inc (Lenexa, KS). Calf serum was from Hyclone Laboratories (Logan, UT). Hemin was obtained from Eastman Kodak (Rochester, NY). Pokeweed mitogen and geneticin (G418) were obtained from GlBCO (Grand Island, NY). Gene Screen Plus and ["P)-dCTP were purchased from New England Nuclear Corp (Boston, MA). Ag-50-XA8 resin was obtained from Biorad (Richmond, CA). Taq polymerase and the reagents for DNA amplification were purchased from Perkin Elmer Cetus (Norwalk, CT) and used as recommended by the manufacturer. All other molecular biology reagents were obtained from Boehringer Mannheim (Indianapolis, IN) and used as suggested by the manufacturer. General laboratory chemicals were from Sigma (St Louis, MO).
Retroviml Vector
The retroviral vector pLJRSVudu% was derived from pW (provided by R. Mulligan. Whitehead Institute, MIT) and contains the bacterial neomycin resistance gene neo under the transcriptional control of the viral long terminal repeat (LTR), and the Escherichia coli DNA repair gene uda, which produces the O'alkylguanine-DNA alkyltransferase protein (Fig 1) . In pURSVudu, the ado gene is under the transcriptional control of the 621-bp fragment of the Rous Sarcoma Virus (RSV) 3' LTR used as the internal promoter.*' Virus produced by $-2 cells" transfected with pWRS- Vudu is referred to as vWRSVadu. One subclone of these 9-2 cells produced the vUudu virus that contains a 1.7-kb deletion of the vURSVudu virus extending from the 3' end of neo to the 5' end of udu (see Fig 1) . This virus was used in the second set of gene transfer experiments. Viral titers of vLJRSVudu were 2 to 5 x lV/infectious particledml and of vWudu were 5 to 10 x lo"/ infectious particleshl.
Cell Cultures
Cells were maintained in 50% Hams F12 medium and 50% Dulbecco's modified Eagle medium supplemented with 10% calf serum at 3PC in 5% CO, vWRSVudu and vWudu retrovirus was harvested from confluent roller bottles of transfected 6-2 cells, concentrated 20-fold with a YM-100 Amicon (Danvers, MA) filter and sterilized by passage through a 0.45-pm GS Millipore (Bedford, MA) filter. Individual $-2 transfected clones were titered for vURSVadu virus production by the ability of the culture supernatant to transmit (3418 resistance (1 mg/mL) :o NIH3T3 cells'"." by limiting dilution and for vWudu production by relative intensity on Southern analysis of unselected. virally infected NIH3T3 cells. No detectable recombinant wild-type retrovirus was present in the viral supernatants used in these experiments; supernatant from NIH3T3 cells infected with $-2 supernatant was unable to produce (3418 resistant cells or polymerase chain reaction PCR-detectable provirus in a secondary infection of NIH3T3 cells. Likewise, serum of recipient animals did not contain infectious helper retrovirus as assayed by two methods; serum did not transmit G418 resistance to NIH3T3 cells and no provirus was detectable by PCR analysis of unselected, serum-cocultured NIH3T3 cells (limit of detection, approximately 100 viral particleshl).
Colony-Fonning Unit Granulocyte-Macrophage (CFU-GM) Progenitor Assay
In vitro C N -G M progenitors were cultured in 0.9% methylcellulose in the presence of 15% voVvol pokeweed mitogen-stimulated For personal use only. on November 11, 2017. by guest www.bloodjournal.org From rat spleen cell-conditioned media prepared as previously described,*' 30% volhrol fetal calf serum, and 10% voVvol Iscove's modified Dulbecco's medium. Mononuclear cells were plated at 105/1 mL Lux plate. The cultures were incubated at 3TC, 5% CO, for 7 to 10 days. Colonies greater than 50 cells were counted and colonies greater than 200 cells were aspirated for analysis of gene transfer (see below).
Nucleic Acid Analysis
Southem analysis. Cellular genomic DNA was prepared as previously de~cribed.~.~' Southern analysis was performed by digesting 20 kg samples of genomic DNA with either Xba I or @n I. Digested DNA was separated by electrophoresis on a 1% agarose gel and transferred to Gene Screen Plus as described.*6 The probes used were the 1.2-kb neo gene and the 1.3-kbada gene labeled with ["PI dCTP with random oligonucleotide primers. Hybridization was performed at 42°C for 48 hours as de~cribed.*~,~' Filters were washed with 0.1% sodium dodecyl sulfate (SDS), 0.1X SSC at 55T, dried, and exposed to Kodak XAR film at -80°C. The expected fragments of genomic DNA derived from cells infected with vLJRSVada and hybridizing with the ada probe are 1.9 kb followingXbn I digestion and 5.7 kb following@n I digestion (see Fig 1) . Genomic DNA isolated from cells infected with vLJada and digested with Xba I or @n I should generate fragments of 3.8 kb that hybridize with the ada or neo probes.
Twenty micrograms of genomic DNA from vLJada was digested with Clal that recognizes a unique site within the provirus 3' to the ada gene (Fig 1) . Digested DNA was then separated by agarose gel electrophoresis, prepared for Southern analysis as above, and hybridized with the ['*P]-labeled ada probe.
Junctional analysis.
PCR
Two micrograms of genomic DNA isolated from various tissues was used as substrate for detection of small amounts of the transduced ada gene by use of the PCR as previously described." Laboratory procedures were used that avoid contamination of genomic DNA with the PCR product or with proviral sequences. DNA from uninfected rats was run as a control in each experiment. Thirty picomoles of two 21-bp oligonucleotides were used in a standard PCR reaction. The PCR generated a 633-bp fragment of the ada gene beginning with the 5' oligo-[+360] 5' ATCAC-CCACGCGTGTCGACTG, and ending with the 3' oligo-[ +972] 5' CAGCAACTGGCTAACGCCATC. Each sample was amplified for 32 cycles (94°C for 60 seconds to denature the DNA, 56°C for 2 minutes for primer annealing, and 72°C for 90 seconds for primer extension). To define the relative efficiency of gene transfer, genomic DNA was subject to limiting dilution before PCR analysis by mixing serial dilutions of 2 p,g genomic DNA isolated from the tissue of an infected rat with increasing amounts of genomic DNA isolated from the same tissue of noninfected rat such that each PCR reaction contained 2 p,g DNA. Twenty microliters of the reaction mixture was electrophoresed on a 2% agarose gel and photographed after ethidium bromide staining or transferred to Gene Screen Plus, hybridized with ['2P]-labeled ada, washed, and exposed to Kodak XAR film as de~cribed.~."
Genomic DNA was also isolated from CFU-GM colonies using a method that allows for the extraction of DNA from less than 1,OOO cell^.^' Briefly, the cells from individual clones were removed from the methylcellulose culture and washed with 5 mL phosphatebuffered saline (PBS) at 4°C. The cell pellets were resuspended in 25 to 50 p,L of PCR buffer containing 25 &mL proteinase K, incubated for 1 hour at 60"C, and heated to 95°C for 10 minutes to inactivate the proteinase K." Twenty-five microliters of lysate was added to the standard PCR reaction, which was performed as above.
Blood specimens were obtained by dorsal tail venipuncture (0.3 mL) or intracardiac venipuncture (2 mL) and anticoagulated in sodium heparin at 10 UlmL. Mononuclear cells were isolated by Ficoll-Hypaque centrifugation and washed once in PBS. Genomic DNA was then extracted from the mononuclear cells by phenolchloroform extraction" or by the crude lysate preparation as described above for CFU-GM."
RESULTS
Fetal Retroviral Injection and Survival
Fetal rat liver was injected in utero with replicationdefective retrovirus at day 11,14,16, or 18 of gestation with, depending on the age, between 5 x lo4 to 5 x lo5 infectious retrovirus/fetus. There was a significant in utero fetal mortality associated with the in utero injections, especially during the initial experiments. However, all animals alive at birth developed normally. The mean fetal survival in rats who were injected with concentrated retrovirus was 32% ( Table 1 ). Fetuses that were injected at day 11 gestation had a significantly lower (17%) rate of survival than did fetuses injected at days 14, 16, or 18 of gestation (mean, 37%). In a second group of experiments, survival of day 16 gestation fetuses that received injections of 100 pL media alone was similar to those injected with 100 pL retrovirus supernatant (16 of 26 in the retrovirus group and 10 of 15 in the media group). Thus, it appears that the in utero injection procedure rather than the retrovirus itself has associated fetal mortality.
Gestational Age-Dependent Gene Transfer
To define whether gene transfer into hematopoietic cells was affected by the gestational age at the time of retroviral infection, rats infected at 11 to 18 days of gestation were killed at 1, 3, and 8 weeks postnatal age and analyzed for the presence of proviral sequences in genomic DNA from liver, BM, spleen and lung. Samples were evaluated for the presence of provirus in genomic DNA by the sensitive PCR method and analyzed for the efficiency of gene transfer by Southern analysis of restriction enzyme-digested genomic Pregnant Sprague-Dawley rats at 11, 14, 16, or 18 days of pregnancy were anesthetized using ether. The uterine horns were externalized.
The liver of each fetus was injected with concentrated retrovirus supernatant using volumes of 25, 50, 100. or 100 pL for fetuses of 11, 14, 16, or 18 days of gestation, respectively. The uterine horns were returned to the abdomen and gestation was allowed to continue to term, which is 22 days. Fetal survival was determined within 24 hours of birth.
For 14 or 16 of gestation with vWRSVad8 were examined for the presence of the provirus by PCR. Twenty-one base pair oligonucleotide primers were constructed t o amplify a 633-bp fragment of the sds gene located within the provirus. The product of a standard amplification reaction of 32 cycles was separated by electrophoresis on a 2% agarose gel, transferred t o Gene Screen Plus, and probed with ["P]-labcled 8d8. Low levels of gene transfer can be detected in BM (Bm), lung (Lu), and liver (Li). Each bracket represents the amplified gene product from the tissues of an individual animal. ( -) indicates genomic DNA from an uninfected rat liver used as a negative control in the PCR reaction. See also in BM thc provirus was dctcctcd in 5 of 8 rats injcctcd at day 11 ofgestation, 10 of 12 rats injcctcd at day 14 to 16, and 4 of 14 rats injcctcd at day 18. In rats injcctcd at day 14 to 16 of gcstation, 7 of 10 BM samplcs with provirus dctcctcd by PCR also had provirus dctcctcd by Southern analysis, whcrcas 0 of 22 rats injcctcd at 11 or 18 days of gcstation had dctcctablc provirus sccn on Southern analysis. Bccausc PCR may detect vcry fcw cclls ( < 1%) carrying thc provirus whilc dctcction by Southcrn analysis of gcnomic DNA requires about 10% of cells to carry the provirus, thcsc rcsults suggest much more cfficicnt gcnc transfcr in rats injcctcd at day 14 to 16 of gcstation than at carlicr or latcr 
times.
Genc transduction was also dctcctcd in othcr tiSSUCS Of animals injcctcd at day 14 to 16 of gcstation but at a lowcr 'Gene transfer for this group was detected only by PCR. For other groups, some tissues had gene transfer detected by PCR and others by Southernanalysis.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From frequency than in the BM. Liver was positive by PCR in 7 of 12 rats (4 of 12 by Southern analysis), spleen in 8 of 12 rats (4 of 12 by Southern analysis), and lung in 6 of 12 rats (3 of 12 by Southern analysis). In contrast, proviral sequences were detected in organs other than BM in only 1 of 14 rats injected at day 18 gestation and in none of the other organs of rats injected at day 11 gestation. No correlation was noted between the estimate of gene copy number and the age of the animal at the time of harvest. In most instances, intact proviral sequences were found when the blots were probed with ["P] ada or neo fragments; however, one liver sample showed a small deletion.
Long-Term Persistence of Retroviius After In Utero Injection
In a separate set of experiments, we determined whether the in utero method of gene transfer could achieve successful long-term gene transduction into one or more hematopoietic cell lineages. Sixteen of 26 fetuses from three pregnant rats injected with vLJuda retrovirus at day 16 of gestation survived and delivered at term. Nine rats were killed at 26 weeks of age for analysis of gene transfer.
To evaluate the presence and persistence of the provirus in a single group of rats over time, white blood cells (WBCs) were isolated from heparinized blood, collected at 4, 18, and 26 weeks of age, and were analyzed by PCR. The provirus was detected by PCR in 6 of 12 animals at 4 weeks of age, 2 of 11 animals at 18 weeks of age, and 6 of 9 animals at postmortem exam at 26 weeks. We may have underestimated the proportion of rats with provirus in their blood cells based on a recent report describing the ability of heparin to interfere with the PCR rea~tion.~'
From rats killed at 26 weeks of age, BM, thymus, blood, spleen, liver, and lung were harvested for genomic DNA and analyzed for gene transduction by PCR and by Southern analysis (Table 3) . Eight of nine animals contained the provirus in the BM by PCR. Of these, three of nine were detected by Southern analysis of the BM at an estimated efficiency in the three rats of between 10% and 90% of the cells carrying the provirus. In one of three of these rats, gene transduction was found in WBCs as well. In four other rats that had provirus detected by PCR in blood cells, provirus was also detected in BM by PCR. The provirus was also detected by PCR in most rats injected with retrovirus in the thymus, spleen, liver, and lung, and to a lesser extent by Southern analysis of genomic DNA. Figure 3 presents a detailed analysis of two rats that contained evidence of provirus in multiple organs at 26 weeks. In rat 16-1 (Fig 3A) provirus was detected by Southern analysis of genomic DNA in BM, liver, and lung. Junctional analysis (Fig 3Ab) to detect an oligoclonal pattern of cell progeny showed one or two bands per tissue with an apparently identically sized band in liver and BM, suggesting a clonal origin to the cells (perhaps a monocyte precursor). Spleen and thymus, which did not contain provirus detectable by Southern, did have provirus detected by PCR (Fig 3Ac) . In rat 16-2 ( Fig 3B) provirus was detected in thymus, liver, lung, and spleen by Southern analysis whereas junctional analysis showed two prominent bands in the thymus but no bands in other tissues. BM provirus was not seen by Southern analysis but was seen by PCR analysis to a 1:300 dilution (Fig 3Bc) . In contrast, PCR analysis of the BM from rat 16-1, which was detected by Southern analysis, detected provirus to a 1:3000 dilution. Thus, rat 16-2 has evidence of a clonal pattern in lymphoid cells but had a relatively low level of gene transduction into BM cells, precluding an analysis of the clonal pattern in these cells. Analysis of expression of the transduced adu gene failed to detect ada mRNA by Northern analysis of total cellular RNA from liver or BM. In addition, no adu derived alkyltransferase protein was detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (data not shown). We next asked whether hematopoietic progenitors from in utero infected animals contained the provirus. BM cells were cultured for CFU-GM in vitro from five animals killed at 26 weeks. Individual progenitors were harvested on day 7 of culture. DNA was isolated and amplified using PCR. A total of 23 CFU-GM colonies were examined. Twelve of 23 CFU-GM contained the provirus (Fig 4) . Each of the four rats examined that contained the provirus in the BM had provirus detected in CFU-GM.
DISCUSSION
We have found that in utero retroviral infection is a promising means of gene transfer into hematopoietic precursors in vivo. When in utero fetal liver injections were performed between day 14 and 16 of gestation, detectable proviral sequences were observed in live-born rats and these sequences persisted until the rats were killed at 26 weeks of age. In our initial experiments, 10 of 12 rats injected at day 14 to 16 of gestation had evidence of gene transfer into hematopoietic cells, and in the second set of Pcrsistcncc of provirus in pcriphcral blood and BM cells as well as in thymus and splccn of 26-wcck-old rats suggcsts that early hcmatopoictic progcnitors had becn transduced. Analysis of uniquc inscrtion sites of the provirus (junctional fragment analysis) in two rats identified an ohgoclonal pattcrn of transduccd cells, suggesting that only a fcw stcm cells had bccn infcctcd or were supporting hematopoiesis at 26 wccks of agc. In the clonal analysis of one rat, the BM and livcr had onc band of identical size, indicating the presence of cclls (perhaps macrophages) derived from thc samc clone in the two organs. Bccausc provirus was dctcctcd in both thc thymus, splcen, and BM of five scparatc rats by PCR (Table 3) , it is possible that a true totipotcnt stcm ccll has bccn infcctcd in thcsc animals. Unfortunately, this could not be confirmed by junctional analysis bccausc the lcvcl of gcnc transfcr was too low to consistently bc identified by Southern analysis of genomic DNA. Altcrnativcly wc may have transduced several com- Bccausc thc fctus is rapidly growing during midgestation, we hypothcsizcd that proliferating totipotent stcm cells would bc susccptiblc to gcnc transfcr in utcro. Wc chose to study thc pcriod bctwccn 11 and 18 days of gestation because in rodcnts hcmatopoictic cells shift from thc yolk sac to thc fctal livkr at about day 10 of gestation."." Hematopoiesis subscqucntly cxpands in thc livcr such that by day 14 to 16 of gestation the fetal liver contains large numbers of hcmatopoictic stcm cclls that make up as much as 0.2% of total cells." At day 15 of gcstation in the rat, nearly 90% of all CFU-granulocyte, crythroid, monocyte, megakaryocyte (CFU-GEMM) arc located in thc fetal liver.'' At approximately day 18 of gestation, the numbcr of hcmatopoictic cells in thc livcr dccrcascs"." as thc BM cavity maturcs and hcmatopoicsis bcgins in the BM whcrc it For personal use only. on November 11, 2017. by guest www.bloodjournal.org From is well developed by about day 20.'' On the basis of these developmental studies, our finding of proviral sequences in the BM of animals transduced in utero by retroviral injection into the liver provides indirect evidence for the migration of hematopoietic stem cells from the liver to the BM. These studies also may explain why the maximum efficiency of gene transfer to BM occurred in animals injected at day 14 to 16 of gestation; at this age the fetal liver contains the greatest proportion of hematopoietic precursors, whereas the BM cavity is still immature and contains few hematopoietic precursors.'' Three issues need to be addressed to optimize this technique of gene transfer: (1) improving the efficiency of retroviral gene transfer; (2) reducing the mortality of the in utero injection; and (3) using vectors that will allow gene expression in hematopoietic cells. The efficiency of gene transfer to BM is related to the number of viral particles injected and the proliferative capacity of the hematopoietic cells infected. Because we injected only 5 x lo4 to 5 x 10' particles into each fetus, we rely on the rapid proliferation of hematopoietic stem cells in the fetus (which is agedependent) to amplify the number of cells that contain the transgene. Higher virus titer may improve the level of gene transduction that takes place.
The second issue, fetal mortality, was a significant problem in our study at each gestational age tested. Fetal demise appeared in large part to be due to the volume injected rather than the presence of retrovirus because it was similar in fetuses injected with either media or retrovirus. Causes could include hemorrhage from needle puncture, abortion secondary to fetal manipulation, or adverse effects of increased pressure due to the volume of fluid injected. Improved techniques of injection and the use of smaller volumes of retroviral supernatant containing higher virus titer may decrease the fetal mortality associated with this procedure.
Third, we have not detected expression of the transduced genes in any of the tissues examined. Northern analysis of total cellular RNA from multiple organs failed to identify a proper transcript for either the uda or neo gene when probed with either a standard DNA probe or a riboprobe."36J7 Further, no bacterial 06alkylguanine-DNA alkyltransferase derived from the udu gene was detected by SDS-PAGE.26 CFU-GM colonies from adult rats infected in utero did not show drug resistance to G418. This lack of expression may indicate that the pLJ-based construct is not optimal for gene expression in hematopoietic cells. We have also been unsuccessful demonstrating expression of vLJRSVudu in mouse CFU-S (data not shown), even though we have shown that the adu and neo genes are expressed in fibroblast cell lines and that transcripts derived from the 5' LTR and the internal RSV promoter are present in vitro.26 Other retroviral constructs may be more likely to express internal genes in hematopoietic cells in
We also observed that nonhematopoietic tissues, specifically liver and lung, contained low levels of transduced provirus. In most instances, the proportion of cells containing the provirus was small, typically less than 5%, and could be detected only by PCR. Our results are similar to those observed by Hatzoglou et al," who identified proviral sequences in a variety of tissues after fetal liver injections. Our studies were designed to target hematopoietic cells, whereas the earlier study was aimed at expressing genes in the liver by performing injections later in development (day 19). Both studies have shown that retroviral-mediated gene transduction in utero can yield long-term, stable gene transfer but that it is not a tissue-specific or restricted process.
In summary, in utero retroviral infection of fetal liver leads to stable gene transduction for at least 6 months of BM hematopoietic progenitors of the developing rat. This finding strongly suggests that early hematopoietic stem cells have been infected without the need to resort to either BM ablation followed by transplantation'.' or special strains of mice with genetic defects in hematopoie~is.'~.~ This model could have application in the analysis of gene transduction in larger animals, and has potential clinical application in the correction of human genetic diseases. For personal use only. on November 11, 2017. by guest www.bloodjournal.org From
